
Share on:
Arcam received an order for five Arcam Q10 systems from Beijing AK Medical, a present customer in China. The systems will be used for volume production of orthopaedic implants.
Beijing AK Medical, an Arcam customer since 2010, announced in August its formal approval from the Chinese State Food and Drug Administration (CFDA) for EBM-manufactured implants. This was the first CFDA marketing approval for an additively manufactured orthopaedic implant.
Arcam Group provides Additive Manufacturing solutions for the production of metal components.
RELATED ARTICLES
Kapstone Manufacturing to Integrate In-House DLyte Dry Electropolishing
Jun 04 2026 , Julie A. Vetalice
5 Packaging Validation Mistakes That Delay FDA Clearance
Jun 01 2026 , Matthew Emerick
Small Joint Implants: A New Era with Medureonâ„¢ Bionateâ„¢
Jun 01 2026 , dsm -firmenich



